Extended Rhythm Monitoring to Assess for Ventricular Arrhythmias After Transcatheter Pulmonary Valve Replacement With the Harmony Valve
- 1 January 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (1) , e014381
Abstract
BACKGROUND: Varying rates of nonsustained ventricular tachycardia (NSVT) have been reported early after transcatheter pulmonary valve replacement (TPVR) with the Harmony valve, but data regarding rhythm outcomes beyond hospital discharge are limited. This study aims to characterize ventricular arrhythmias after Harmony TPVR from implant through mid-term follow-up. METHODS: Ventricular arrhythmia data from postimplant telemetry and follow-up extended rhythm monitoring (ERM) were analyzed after Harmony TPVR. RESULTS: Fifty-four patients with tetralogy of Fallot (n=39), valvar pulmonary stenosis (n=10), or pulmonary atresia with intact ventricular septum (n=5) were studied; 22% had prior NSVT and 24% were on prior rhythm medication. On postimplant telemetry, 27 patients (50%) had NSVT, including 1 who had torsade de pointes, but most had <5 episodes. Pre-TPVR NSVT or rhythm medications, diagnosis other than tetralogy, and substantial device contact with the myocardium were associated with more frequent NSVT on telemetry. Ten patients (19%) were started on a new antiarrhythmic medication. On discharge ERM, 37% of patients had NSVT, most with <5 episodes and only 13% with NSVT beyond 5 days post-discharge. On follow-up ERM, 14% of patients had a single episode of NSVT and 1 had 5 episodes. During follow-up, antiarrhythmic medications were discontinued in 8 of 10 patients and no patients died or had sustained ventricular tachycardia. CONCLUSIONS: NSVT and ventricular ectopy were common early after TPVR but were infrequent in most cases and diminished rapidly after discharge. The incidence of NSVT on follow-up ERM was similar to preimplant incidence. Few patients had antiarrhythmic medications initiated, and most were discontinued on follow-up. There were no major arrhythmic events after discharge.Keywords
This publication has 22 references indexed in Scilit:
- Early Outcomes From a Multicenter Transcatheter Self-Expanding Pulmonary Valve Replacement RegistryJACC, 2024
- Ventricular arrhythmias following balloon‐expandable transcatheter pulmonary valve replacement in the native right ventricular outflow tractCatheterization and Cardiovascular Interventions, 2023
- Ventricular arrhythmias following transcatheter pulmonary valve replacement with the harmony TPV25 deviceCatheterization and Cardiovascular Interventions, 2022
- Transcatheter Pulmonary Valve Replacement With the Sapien ProsthesisJACC, 2020
- Ventricular Arrhythmia and Life-Threatening Events in Patients With Repaired Tetralogy of FallotThe American Journal of Cardiology, 2020
- Slow Conducting Electroanatomic IsthmusesJACC: Clinical Electrophysiology, 2018
- Ventricular arrhythmias immediately following transcatheter pulmonary valve implantation: A cause for concern?Catheterization and Cardiovascular Interventions, 2017
- Ventricular Tachycardia in Congenital Pulmonary StenosisCardiac Electrophysiology Clinics, 2016
- Arrhythmic burdens in patients with tetralogy of Fallot: A national database studyHeart Rhythm, 2015
- Implantation of the Melody Transcatheter Pulmonary Valve in Patients With a Dysfunctional Right Ventricular Outflow Tract ConduitJACC, 2009